# Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

> **NCT00091936** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 592 (estimated)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Didanosine
- **DRUG:** Efavirenz
- **DRUG:** Lamivudine
- **DRUG:** Standard TB treatment

## Key facts

- **NCT ID:** NCT00091936
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 592 (ESTIMATED)
- **Last updated:** 2010-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091936, "Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00091936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*